Net selling: insiders sold $88.7M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (3)
Millennium
$94.0M
added
Two Sigma
$71.7M
added
JPMorgan Chase
$32.6M
added
No tracked top-trader positions in ONC as of Oct 24, 05:43 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Aug 5, 2026
Period ending
Jun 30, 2026
Earnings per share
$1.63 expected
Revenue
Financial statements: Alpha Vantage
Estimates as of Oct 24, 2026
EPS expected
$1.56 to $2.24
Revenue expected
12 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 5, 2026 | $2.05 / $1.63Yahoo Finance | +25.66% beat | $1.71B No estimate | Unavailable |
| Mar 31, 2026 | May 6, 2026 | $1.96 / $0.81Yahoo Finance | +143.25% beat | $1.51B No estimate | Unavailable |
| Dec 31, 2025 | Feb 26, 2026 | $0.58 / $1.30Yahoo Finance | -55.33% miss | $1.50B No estimate | Unavailable |
| Sep 30, 2025 | Nov 6, 2025 | $1.09 / $0.86Yahoo Finance | +26.99% beat | $1.41B No estimate | Unavailable |
| Jun 30, 2025 | Aug 6, 2025 | $0.84 / $0.26Alpha Vantage | +$0.58 beat | $1.32B No estimate | Unavailable |
| Mar 31, 2025 | May 7, 2025 | $0.01 / -$0.74Alpha Vantage | +101.35% beat | $1.12B No estimate | Unavailable |
| Dec 31, 2024 | Feb 27, 2025 | -$1.43 / -$1.01Alpha Vantage | -41.58% miss | $1.13B No estimate | Unavailable |
| Sep 30, 2024 | Nov 12, 2024 | -$1.15 / -$1.11Alpha Vantage | -3.60% miss | $1.00B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.41B | $1.50B | $1.51B | $1.71B |
| Cost of what it sold | $196.5M | $142.4M | $167.2M | $174.5M |
| Gross profit | $1.22B | $1.36B | $1.35B | $1.53B |
| What it spent | ||||
| Research and development | $523.7M | $615.4M | $541.2M | $612.3M |
| Sales and admin | $529.0M | $555.3M | $555.1M | $593.2M |
| Total operating expenses | $1.05B | $1.17B | $1.10B | $1.21B |
| What was left | ||||
| Operating profit | $163.1M | $185.0M | $249.9M | $325.0M |
| Interest on debt | — | $58.2M | $32.9M | $39.7M |
| Profit before tax | $147.2M | $149.2M | $259.2M | $312.5M |
| Tax | $22.3M | $82.7M | $31.9M | $75.5M |
| Net profit | $124.8M | $66.5M | $227.4M | $237.0M |
| EBITDA | $184.4M | $249.0M | $333.2M | $392.7M |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Citi Maintains BeiGene(ONC.US) With Buy Rating, Maintains Target Price $466
BullishOct 20RBC Capital Maintains BeiGene(ONC.US) With Buy Rating, Maintains Target Price $459
BullishOct 17BeiGene(ONC.US) Director Sells US$10.89 Million in Common Stock
BearishOct 16Truist Financial Maintains BeiGene(ONC.US) With Buy Rating, Announces Target Price $420
BullishOct 923 macro signals shaping ONC right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results